Bo Yan Zhang
Hoofd Techniek/Wetenschap/O&O bij Beijing Mabworks Biotech Co., Ltd.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Feng Li | M | 52 |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 13 jaar |
| Tao Zhu | M | 51 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 jaar |
| Ren Yu Li | M | 63 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 jaar |
| Tian Wang | M | 33 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 jaar |
| Yiu Leung Cheung | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 jaar |
| Wen Qi Hu | M | 62 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 jaar |
| Xu Dong Jia | M | 58 |
Nanjing University
| 31 jaar |
| Xiong Sheng Yang | M | 64 |
Nanjing University
| 29 jaar |
| Hui Fang Liu | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 jaar |
| Yan Qi | F | 54 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 17 jaar |
| Pei Ye | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 jaar |
| Zhan Chao Liang | M | 40 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 8 jaar |
| Jin Jin Liang | M | 55 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 jaar |
| Jing Zhang | F | 42 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 jaar |
| Ting Li | F | 35 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 jaar |
| Wing Sze Yu | F | 41 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Tong Li | F | 49 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 jaar |
| Qi Li | M | 44 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Wen Bin Miao | M | 45 |
Nanjing University
| 4 jaar |
| Qiao Liang Zhang | F | 56 |
Lanzhou University
| 11 jaar |
| Quan Rong Gu | M | 60 |
Nanjing University
| 3 jaar |
| Mao Li Huang | F | 49 |
Nanjing University
| 6 jaar |
| Xiong Yin | M | 58 |
Lanzhou University
| 6 jaar |
| Haichuan Qian | M | - |
Nanjing University
| 7 jaar |
| Xin Qu | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| De Cai Yang | M | 59 |
Nanjing University
| 6 jaar |
| Jian Guo Ma | M | 64 |
Lanzhou University
| 6 jaar |
| Hao Dong Wu | M | 60 |
Nanjing University
| 5 jaar |
| Yong Gao | M | 51 |
Nanjing University
| 6 jaar |
| Jun Lai Wang | M | 53 |
Nanjing University
| 4 jaar |
| Ye Wu | M | 45 |
Nanjing University
| 4 jaar |
| Xi Jun Shen | M | 63 |
Nanjing University
| 2 jaar |
| Shaowei Yang | M | 48 |
Nanjing University
| 4 jaar |
| Yumin Wan | M | 53 |
Nanjing University
| 4 jaar |
| Hong Cong | M | 52 |
Nanjing University
| 4 jaar |
| Chen Ning Shi | M | 50 |
Nanjing University
| 3 jaar |
| Ting Xu | M | 51 |
Nanjing University
| 4 jaar |
| Zefeng Mei | M | 46 |
Nanjing University
| 4 jaar |
| Ai Feng Lyu | M | 47 |
Nanjing University
| 4 jaar |
| Xin Jian | M | 46 |
Nanjing University
| 4 jaar |
| Jianyou Xiao | M | 55 |
Nanjing University
| 3 jaar |
| Cheng Zhang | M | 50 |
Nanjing University
| 4 jaar |
| Ying Chun Xue | F | 50 |
Nanjing University
| 4 jaar |
| Tao Wang | M | 47 |
Nanjing University
| 4 jaar |
| Xia Zhao | F | 43 |
Nanjing University
| 4 jaar |
| Ke Qing Cai | M | 48 |
Nanjing University
| 3 jaar |
| Yu Wang | M | 46 |
Nanjing University
| 4 jaar |
| Fan Lu | M | - |
Nanjing University
| 4 jaar |
| Yang Weng | F | 52 |
Nanjing University
| 4 jaar |
| Zhen Gang Ge | M | 48 |
Nanjing University
| 4 jaar |
| Ming Zhong | M | 54 |
Nanjing University
| 4 jaar |
| Jia Qing Wu | M | 46 |
Nanjing University
| 4 jaar |
| Xiao Ning Guo | M | 46 |
Nanjing University
| 4 jaar |
| Jun Sheng Ma | M | 49 |
Nanjing University
| 4 jaar |
| Yuan Kun Cao | M | 58 |
Nanjing University
| 3 jaar |
| Wei Dong Deng | M | 57 |
Nanjing University
| 3 jaar |
| Xiao Lin Xu | M | 47 |
Nanjing University
| 4 jaar |
| Chun Hai Fan | M | 51 |
Nanjing University
| 7 jaar |
| Huichuan Zhou | M | 51 |
Nanjing University
| 4 jaar |
| Peng Guo | M | 49 |
Nanjing University
| 4 jaar |
| Gang Chen | M | 54 |
Nanjing University
| 1 jaar |
| Tao Zou | M | 54 |
Nanjing University
| 3 jaar |
| Wee Koon Heng | M | 54 |
Nanjing University
| 2 jaar |
| Xiao Hong Zhu | F | 52 |
Nanjing University
| 4 jaar |
| Ping Wang | M | 54 |
Nanjing University
| 4 jaar |
| Yi Zhi Tang | M | 51 |
Nanjing University
| 4 jaar |
| Qidong Zhang | M | - |
Nanjing University
| 6 jaar |
| Zhi Qiang Zhang | M | 58 |
Nanjing University
| 1 jaar |
| Jie Su | M | 50 |
Nanjing University
| 4 jaar |
| Lu Guo | M | 47 |
Nanjing University
| 4 jaar |
| Ke Ge | M | 51 |
Nanjing University
| 4 jaar |
| Aaron Tong | M | - |
Nanjing University
| 4 jaar |
| Jianwu Li | M | 53 |
Nanjing University
| 4 jaar |
| Ya Yu | M | 68 |
Nanjing University
| 2 jaar |
| Alex Ba | M | - |
Nanjing University
| 4 jaar |
| Yin Hui Li | M | 56 |
Nanjing University
| 2 jaar |
| Ning Lu | M | 56 |
Nanjing University
| 4 jaar |
| Peng Hui Chen | M | 52 |
Nanjing University
| 4 jaar |
| Qixiang Sun | M | - |
Nanjing University
| 3 jaar |
| Xue Hua Shen | M | 47 |
Nanjing University
| 4 jaar |
| Yi Zhang | M | 51 |
Nanjing University
| 4 jaar |
| Dong Tao Yang | M | 67 |
Nanjing University
| 3 jaar |
| Feng Ge | M | 47 |
Nanjing University
| 4 jaar |
| Ming Li | F | - |
Nanjing University
| 4 jaar |
| Xiao Guang Wu | M | 48 |
Nanjing University
| 4 jaar |
| Qiang Zheng | M | 51 |
Nanjing University
| 4 jaar |
| Wei Zhu | M | 53 |
Nanjing University
| 4 jaar |
| Yong Liu | M | 57 |
Nanjing University
| 4 jaar |
| Shun Huang | M | 50 |
Nanjing University
| 4 jaar |
| Gang Shen | M | 46 |
Nanjing University
| 4 jaar |
| Hai Tao Lin | M | 48 |
Nanjing University
| 4 jaar |
| Zhang Jing | M | - |
Nanjing University
| 3 jaar |
| Han Qiu | F | 49 |
Nanjing University
| 4 jaar |
| Wan Lei Shao | M | 56 |
Nanjing University
| 4 jaar |
| Min Zhu | M | - |
Nanjing University
| 4 jaar |
| Xiao Dong Hou | M | 51 |
Nanjing University
| 3 jaar |
| Ruo Chuan Zhu | M | 49 |
Nanjing University
| 4 jaar |
| Gang Zhai | M | 49 |
Nanjing University
| 4 jaar |
| Ming Tian | M | 63 |
Nanjing University
| 1 jaar |
| Zhen Qiang Huang | M | 46 |
Nanjing University
| 4 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| China | 100 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Bo Yan Zhang
- Persoonlijk netwerk
